Tag Archives: Future
Apple Keeps Its Moat, and Its Future, Firmly Intact
The company from Cupertino brings the textbook into the 21st century and keeps its innovative edge sharp as a razor.
Fool.com: The Motley Fool
Is A Career In Financial Planning In Your Future?
Take our quiz to find out whether you’re suited for this line of work.
Investopedia: Articles and Tutorials
Cramer: Our Future Linked to EuropeThe Future Of NeuroMetrix
NeuroMetrix (NURO) has been through a lot since becoming a public company. The share price skyrocketed with the initial success of the NC-Stat testing device only to fall with it over the past five years.
Today, this once highflyer is sitting under two dollars with a market cap of around $ 7 million, and $ 11.7 million in the bank. What caused this collapse and what is new today?
NeuroMetrix was once a Robin Hood story: the company stole from the neurologists, gave to the family practitioners, and made awesome margins in doing so. NeuroMetrix took a nerve velocity test; a standard neuropathy test for a neurologist called NC-Stat, and made it less invasive. The company then introduced it as part of GP (general practitioners) office visit. The test helped the GPs make better diagnoses for a broad assortment of neurological problems, as well as increase profit margins; it was a win-win.
401(k) Owners Pray Markets Are Kind To Their Future
Over the last two decades, employers have been shutting down defined-benefit pension plans and steering their workers into 401(k)-type savings plans. But the returns on many of these retirement funds have been dismal for more than a decade.
3 Small Cap Biotech Companies With Future Potential
Spencer Knight submits:
As the general market carries downward momentum due to signs of a slowing national and world economy, many investors are wondering where to place their money. One way investors can keep a portfolio in the green is investing in companies that have great potential during the economic slowdown. Three companies that have a very good chance of moving up in the next 10-12 months are Adventrx Pharmaceuticals (ANX), BioSante Pharmaceuticals (BPAX) and Antares Pharmaceuticals (AIS).
These three companies are good long term investments for three reasons. First, all three companies have FDA action dates during the fourth quarter of 2011 and the first half of 2012. Secondly, these companies should be releasing data from clinical trials of new drugs during that same time frame; and as many small cap investors know, strong data can cause big jumps in the stock price. Lastly, due to the small market value of these
